Since 2012 Adam has been a developer working predominantly with small to medium-sized enterprises. He specialises in delivering added value to startups needing to expand on-line without distracting from their core activities. He is also experienced in software development and digital goods delivery having transitioned several eBooks and mobile-web apps from prototyping to production.
From 2001-2011 Adam was a project manager for the Japanese pharmaceutical company Eisai. He focused on the genetics of Alzheimer's disease, mining the interfaces between human genome project databases and laboratory wet-work. His innovations led to several patent applications. He is the author of the popular science book "3000 Days of Dementia".
Adam holds a PhD from the University of Manchester in the United Kingdom.
If the scope of the work grows, or a client has specialist specs or constraints we can offer partnership with a variety of trusted associates located internationally.